DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Women's Health Homepage

Putting the patient at the center of breast care Insights from Agnes Berzsenyi, president and CEO of GE Healthcare Women’s Health

Beyond detection: How DBT utilization rates impact facility benchmarks New evidence suggests 3D mammo could be as beneficial to providers as it is to patients

Merit Medical Systems closes acquisition of Cianna Medical Deal worth $135 million with possible additional incentivized payments

Remembering Dr. Nancy Cappello A patient advocate and champion of breast density awareness has passed away, but not without leaving her mark on the world

Screenings reduce risk of breast cancer death by 47-60 percent: study New research confirms what most physicians have long believed

Could a new technique make ultrasound interpretation easier? Enhanced contrast, considers intensity and duration of echoes

DBT detects 34 percent more cancers than 2D mammo Increased recall rate should not be a concern, expert says

Are women at low risk undergoing unneeded imaging due to dense breasts? Breast density notification laws may have unintended consequences

Is AI a match for manual interpretation of breast density? Study equates algorithm to experienced mammographer

Etta Pisano American College of Radiology names chief research officer

Digital mammo detects more cancer, but also more false positives: study

by John W. Mitchell , Senior Correspondent
Although digital imaging is more effective in finding breast cancer, the newer technology also results in higher abnormal interpretations. This, in turn, results in more biopsies on benign tumors, according to a study by the Breast Cancer Surveillance Consortium (BCSC) just published in Radiology.

However, women should know that with each breakthrough technology, the trade-off between early detection and false positives gets better.

Story Continues Below Advertisement

Click to visit GE Healthcare Service Shop for ultrasound probe solutions

Get reliable ultrasound probe replacements, faster repair, and service coverage you can count on with GE Healthcare. Service Shop gives customers on-demand access to over 100 OEM new, used, and refurbished probe replacements.



"In order to increase breast cancer detection one has to accept higher recall rates to some extent," said Dr. Stamatia Destounis, managing partner at Elizabeth Wende Breast Care, a screening center, and a member of the BCSC public information network.

The study included data from six BCSC registries comprising 418 radiologists and 92 radiology facilities. Mammography indication and assessments were collected on women undergoing diagnostic digital mammography and linked with cancer diagnoses from state cancer registries. The database included 401,548 examinations conducted from 2007 to 2013 on 265,360 women.

The study was a follow-up to an original 2005 study on the performance of diagnostic mammography in the U.S. At the time, film mammography was the standard.

With digital technology replacing film, the researchers decided it was time to revisit the old benchmarks. The latest study found that breast cancer detection rates increased from 25.3 per 1,000 exams to 34.7 per 1,000. The increase is attributed to the wider use of digital mammography.

"The newer technology involving digital showed an improvement in lesion detection and higher cancer detection," said Destounis. "Improvement of image quality is so important in identifying subtle cancers and increasing cancer detection."

However, along with the increase in detection, the abnormal interpretation rate, or the rate at which women are called back for biopsy, rose from 8.0 percent in 2005 to 12.6 percent in the new study.

Destounis predicted that such false positives that require biopsies on benign masses will likely decrease as the newer technology becomes the standard.

"Since this time period [of the study] many additional new technologies have emerged, such as digital breast tomosynthesis. This 3-D mammogram reduces recall rates and reduces false positive callbacks, and unnecessary workups," she said.

According to Destounis, a possible limitation on the study findings is that the study was conducted by a diverse range of radiology practices across geographical areas in the U.S. A BCBS study source also noted that in Europe call backs for abnormal findings were not nearly as high as in the U.S. This was attributed to the European practice of double reads, where two radiologists review a mammography image.

Looking into the future, Destounis noted that genetic risk is coming more into the forefront as a new form of breast cancer screening. This, she said, will be an opportunity to collect risk factors for each patient to understand if there is any difference in patient populations examined using the old film screening mammography technology.

Women's Health Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED